Reducing blood product waste through the implementation of a four-step protocol during the COVID-19 pandemic

İbrahim Halil Dikici; Sahre G. Özpolat

Makale detayları

Reducing blood product waste through the implementation of a four-step protocol during the COVID-19 pandemic

Yazarlar:

İbrahim Halil Dikici | Sahre G. Özpolat

Yayıncı:

Cukurova University

Ana Başlıklar:

Çocuk Hematolojisi ve Onkolojisi

Dergi:

Cukurova Medical Journal Vol.49 Issue 2, pp.296-303

Belge Tipi:

Makale

Yayın Tarihi:

6/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001320782

pISSN:

2602-3032

Anahtar kelimeler:

Özet:

 Purpose: Blood banking is critical for patients who require transfusions. Blood banks must stock blood products and update their inventory depending on the transfusion demands of hospitals. This demand subject to fluctuations caused by factors such as seasonal variations, emergent medical situations, and disasters. Unexpected changes in transfusion demand also have the potential to affect the number of waste blood products, thereby exacerbating the economic burden borne by blood centers. Our aim in this study is to reduce the destruction rates of blood products. Materials and Methods: In this study, we evaluated the number and cause of discarded blood products in a tertiary hospital in the southeast of Turkey between 2019 and 2022. We also analyzed the effect of the COVID-19 pandemic on blood product waste. In addition, we developed a four-step protocol to reduce wasted blood products in our center. Results: In the first year of the study, the wastestock WS ratio was 3.0 for packed red blood cells pRBCs and 9.2 for platelets PLTs. However, this ratio increased to 3.2 for pRBCs and 10.1 for PLTs during the COVID-19 restrictions in 2020. Upon the implementation of the four-step protocol, the WS ratio decreased for both pRBCs 2.3 and PLTs 6.9 in 2021, but this trend continued for only pRBCs 1.8 in 2022. Conclusion: The number of waste products increased during the COVID-19 restrictions in our center. After we developed the four-step protocol, the waste of pRBCs decreased for two consecutive years, but this was not observed for other blood products. To verify our results, the presented 4-step protocol should be tested in a larger center over a longer period.

 Purpose: Blood banking is critical for patients who require transfusions. Blood banks must stock blood products and update their inventory depending on the transfusion demands of hospitals. This demand subject to fluctuations caused by factors such as seasonal variations, emergent medical situations, and disasters. Unexpected changes in transfusion demand also have the potential to affect the number of waste blood products, thereby exacerbating the economic burden borne by blood centers. Our aim in this study is to reduce the destruction rates of blood products. Materials and Methods: In this study, we evaluated the number and cause of discarded blood products in a tertiary hospital in the southeast of Turkey between 2019 and 2022. We also analyzed the effect of the COVID-19 pandemic on blood product waste. In addition, we developed a four-step protocol to reduce wasted blood products in our center. Results: In the first year of the study, the wastestock WS ratio was 3.0 for packed red blood cells pRBCs and 9.2 for platelets PLTs. However, this ratio increased to 3.2 for pRBCs and 10.1 for PLTs during the COVID-19 restrictions in 2020. Upon the implementation of the four-step protocol, the WS ratio decreased for both pRBCs 2.3 and PLTs 6.9 in 2021, but this trend continued for only pRBCs 1.8 in 2022. Conclusion: The number of waste products increased during the COVID-19 restrictions in our center. After we developed the four-step protocol, the waste of pRBCs decreased for two consecutive years, but this was not observed for other blood products. To verify our results, the presented 4-step protocol should be tested in a larger center over a longer period.

 Purpose: Blood banking is critical for patients who require transfusions. Blood banks must stock blood products and update their inventory depending on the transfusion demands of hospitals. This demand subject to fluctuations caused by factors such as seasonal variations, emergent medical situations, and disasters. Unexpected changes in transfusion demand also have the potential to affect the number of waste blood products, thereby exacerbating the economic burden borne by blood centers. Our aim in this study is to reduce the destruction rates of blood products. Materials and Methods: In this study, we evaluated the number and cause of discarded blood products in a tertiary hospital in the southeast of Turkey between 2019 and 2022. We also analyzed the effect of the COVID-19 pandemic on blood product waste. In addition, we developed a four-step protocol to reduce wasted blood products in our center. Results: In the first year of the study, the wastestock WS ratio was 3.0 for packed red blood cells pRBCs and 9.2 for platelets PLTs. However, this ratio increased to 3.2 for pRBCs and 10.1 for PLTs during the COVID-19 restrictions in 2020. Upon the implementation of the four-step protocol, the WS ratio decreased for both pRBCs 2.3 and PLTs 6.9 in 2021, but this trend continued for only pRBCs 1.8 in 2022. Conclusion: The number of waste products increased during the COVID-19 restrictions in our center. After we developed the four-step protocol, the waste of pRBCs decreased for two consecutive years, but this was not observed for other blood products. To verify our results, the presented 4-step protocol should be tested in a larger center over a longer period.

 Amaç: Kan bankacılığı, transfüzyona ihtiyaç duyan hastalar için kritik öneme sahiptir. Kan bankalarının kan ürünlerini stoklamaları ve hastanelerin transfüzyon taleplerine göre stoklarını güncellemeleri gerekmektedir. Bu talep mevsimler, acil durumlar ve afetler gibi bazı faktörler tarafından değiştirilebilir. Transfüzyon talebindeki beklenmeyen değişiklikler atık kan ürünlerinin sayısını da etkileyebilir. Atık ürünler kan merkezlerinin maliyet yükünü artırabilmektedir. Bu çalışmada amacımız kan ürünlerinin imha oranlarını düşürmektir. Gereç ve Yöntem: Bu çalışmada, 2019-2022 yılları arasında Türkiyenin güneydoğusundaki üçüncü basamak bir hastanede atık kan ürünlerinin sayısını ve nedenini değerlendirdik. Ayrıca COVID-19 salgınının atık ürünler üzerindeki etkisini de analiz ettik. Ayrıca merkezimizde atık ürünlerin azaltılmasına yönelik 4 aşamalı bir protokol geliştirdik. Bulgular: Çalışmanın ilk yılında atıkstok WS oranı kırmızı kan hücreleri pRBCler için 3,0 ve trombositler PLTler için 9,2 idi. Ancak bu oran 2020 yılında Kovid-19 kısıtlamaları sırasında pRBCler için 3,2ye, PLTler için ise 10,1e yükseldi. 4 adımlı protokolü kullanmaya başladıktan sonra, 2021de pRBCler 2,3 ve PLTler 6,9 için WS oranı düştü ancak bu eğilim 2022de yalnızca pRBCler 1,8 için devam etti, ancak PLTler için aynı durum söz konusu değildi. Sonuç: Merkezimizde COVID-19 kısıtlamaları sırasında atık ürün sayısında artış yaşandı. 4 adımlı protokolü geliştirdikten sonra, pRBClerin israfı art arda 2 yıl boyunca azaldı ancak diğer kan ürünleri için bu azalma olmadı. Sonuçlarımızı doğrulamak için 4 adımlı protokolü daha büyük bir merkezde daha uzun bir çalışma süresi boyunca test etmemiz gerekiyor.

Makale detayları

Reducing blood product waste through the implementation of a four-step protocol during the COVID-19 pandemic

Yazarlar:

İbrahim Halil Dikici | Sahre G. Özpolat

Yayıncı:

Cukurova University

Ana Başlıklar:

Çocuk Hematolojisi ve Onkolojisi

Dergi:

Cukurova Medical Journal Vol.49 Issue 2, pp.296-303

Belge Tipi:

Makale

Yayın Tarihi:

6/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001320782

pISSN:

2602-3032

Blood banking

Blood product wastage

Covid 19

4-step protocolKan bankacılığı

kan ürünleri israfı

COVID-19

4 aşamalı protokol

Sayı

Makale detayları

Yazarlar: İbrahim Halil Dikici | Sahre G. Özpolat

Yayıncı: Cukurova University

Ana Başlıklar: Çocuk Hematolojisi ve Onkolojisi

Dergi: Cukurova Medical Journal Vol.49 Issue 2, pp.296-303

Belge Tipi: Makale

Yayın Tarihi: 6/2024

Belge Dili: İngilizce

Document ID (Org No.): 2001320782

pISSN: 2602-3032

Sayı

Yazarlar:

İbrahim Halil Dikici | Sahre G. Özpolat

Yayıncı:

Cukurova University

Ana Başlıklar:

Çocuk Hematolojisi ve Onkolojisi

Dergi:

Cukurova Medical Journal Vol.49 Issue 2, pp.296-303

Belge Tipi:

Makale

Yayın Tarihi:

6/2024

Belge Dili:

İngilizce

Document ID (Org No.):

2001320782

pISSN:

2602-3032